Highlights and Quick Summary
- Weighted Average Shares Growth for the quarter ending September 30, 2023 was -5.52% (a -101.59% decrease compared to previous quarter)
- Year-over-year quarterly Weighted Average Shares Growth decreased by -101.0%
- Annual Weighted Average Shares Growth for 2022 was 1.54% (a Infinity% increase from previous year)
- Annual Weighted Average Shares Growth for 2021 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Weighted Average Shares Growth of Prime Medicine, Inc.
Most recent Weighted Average Shares Growthof PRME including historical data for past 10 years.Interactive Chart of Weighted Average Shares Growth of Prime Medicine, Inc.
Prime Medicine, Inc. Weighted Average Shares Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -5.52% | 347.26% | 367.53% | – | – |
| 2022 | – | – | – | 549.58% | 1.54% |
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology